Aminocamptothecin colloidal dispersion
Term · Oncology and biomedicine · MLC-T-ONC-010028
A colloidal dispersion formulation of 9-Aminocamptothecin, a water-insoluble camptothecin derivative. Aminocamptothecin binds to the nuclear enzyme topoisomerase I, thereby inhibiting repair of single-strand DNA breakages. Because the terminal lactone ring of aminocamptothecin required for the agent's antitumor activity spontaneously opens under physiological conditions to an inactive carboxy form, the drug must be administered over an extended period of time to achieve effective cytotoxicity.
| Identifier | MLC-T-ONC-010028 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | 9-aminocamptothecin colloidal dispersion; 9AC colloidal dispersion |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-010028",
"term": "Aminocamptothecin colloidal dispersion",
"field": "Oncology and biomedicine",
"definition": "A colloidal dispersion formulation of 9-Aminocamptothecin, a water-insoluble camptothecin derivative. Aminocamptothecin binds to the nuclear enzyme topoisomerase I, thereby inhibiting repair of single-strand DNA breakages. Because the terminal lactone ring of aminocamptothecin required for the agent's antitumor activity spontaneously opens under physiological conditions to an inactive carboxy form, the drug must be administered over an extended period of time to achieve effective cytotoxicity.",
"synonyms": [
"9-aminocamptothecin colloidal dispersion",
"9AC colloidal dispersion"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/aminocamptothecin-colloidal-dispersion/"
}
Record 972 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.